25 mg Label (5624fa69 Eae5 43bf Aa7e 379266edd77f 01)
Erlotinib Tablet, Film Coated
Product Images NDC 70771-1521
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Erlotinib (NDC 70771-1521). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Zydus Lifesciences Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
100 mg Label (5624fa69 Eae5 43bf Aa7e 379266edd77f 02)
This is a medication package containing 30 tablets of Erlotinib. The usual dosage information is available in the package insert. The package is child-resistant and should be kept out of the reach of children. The manufacturer is Zydus Cadila Healthcare L. The temperature range for storage is 59°F to 86°F. This medication requires a prescription.*
150 mg Label (5624fa69 Eae5 43bf Aa7e 379266edd77f 03)
This is a package of Erlotinib tablets, containing 30 tablets of 150mg each. The usual dosage information is provided in the package insert. The tablets are film-coated and each tablet contains 163.9g of et hydrochloride equivalent to 150mg of e. The package is manufactured by Gadia Healthcare Ltd, located in Ahmedabad, India. The package is child-resistant and should be kept out of reach of children. The storage temperature of the package must be between 20-25°C (68°F to 77°F).*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
